HI SB253 | 2022 | Regular Session
Note: Carry Over of previous SB253
Status
Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 22 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: Senate Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Permits qualifying patients to be reimbursed by health insurers, mutual benefit societies, and health maintenance organizations for amounts spent on medical cannabis and manufactured cannabis products. Limits the monthly amount of reimbursement. Requires the auditor to conduct impact assessment reports.
Title
Relating To Medical Cannabis.
Sponsors
| Sen. Rosalyn Baker [D] | Sen. Stanley Chang [D] | Sen. Mike Gabbard [D] | Sen. Chris Lee [D] |
| Sen. Clarence Nishihara [D] | Sen. Karl Rhoads [D] | Sen. Joy San Buenaventura [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-12-10 | Carried over to 2022 Regular Session. | |
| 2021-01-25 | Senate | Referred to HTH, CPN. |
| 2021-01-22 | Senate | Passed First Reading. |
| 2021-01-22 | Senate | Introduced. |
Same As/Similar To
SB253 (Carry Over) 2021-01-25 - Referred to HTH, CPN.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=253&year=2022 |
| Text | https://www.capitol.hawaii.gov/session2022/bills/SB253_.HTM |
